Sean Sheridan, in an article published in Law360, provides an overview of recent high-profile court cases that have addressed the issue of patentable subject matter. The article also describes how these decisions are changing patent examination at the U.S. Patent and Trademark Office and discusses how the changing scope of patent-eligible subject matter may impact intellectual property valuations and transactions in the life sciences field. To read the article, click the link below.
A look at Chinese courts’ new approach to IP damages
In this Law360 article, Fei Deng, Hong Qiao, and Yi Cheng examine the trend of Chinese courts toward awarding larger non-statutory damage awards in IP cases....